Abbott Laboratories Company Profile (NYSE:ABT)

Analyst Ratings

Consensus Ratings for Abbott Laboratories (NYSE:ABT) (?)
Ratings Breakdown: 6 Hold Rating(s), 15 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $46.71 (8.21% upside)

Analysts' Ratings History for Abbott Laboratories (NYSE:ABT)
Show:
DateFirmActionRatingPrice TargetActions
7/21/2016Barclays PLCBoost Price TargetOverweight$48.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2016Jefferies GroupBoost Price TargetBuy$45.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016Edward JonesUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016BMO Capital MarketsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016S&P Equity ResearchReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016GabelliReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016BTIG ResearchReiterated RatingBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Piper Jaffray Cos.DowngradeOverweight -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2016Cowen and CompanyReiterated RatingNeutral -> Buy$44.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2016First GlobalDowngradeOutperform -> MarketperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016Royal Bank Of CanadaReiterated RatingOutperform$45.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Stifel NicolausBoost Price TargetBuy$42.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Leerink SwannBoost Price TargetMarket Perform$37.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2016Deutsche Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016ArgusUpgradeHold -> Buy$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Raymond James Financial Inc.Lower Price TargetOutperform$46.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Goldman Sachs Group Inc.Lower Price TargetNeutral$44.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016William BlairDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2016Bank of America Corp.Reiterated RatingBuy$53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/4/2016Morgan StanleyDowngradeOverweight -> Equal Weight$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2015Evercore Partners Inc.Initiated CoverageBuy$54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2015Evercore ISIInitiated CoverageBuy$54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2015JPMorgan Chase & Co.Boost Price TargetNeutral$46.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for Abbott Laboratories (NYSE:ABT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/19/2016        
7/20/2016Q216$0.53$0.55$5.24 billion$5.30 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/20/2016Q116$0.39$0.41$4.77 billion$4.90 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016Q415$0.61$0.62$5.31 billion$5.20 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/21/2015Q315$0.53$0.54$5.16 billion$5.15 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/22/2015Q215$0.50$0.52$5.15 billion$5.20 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/22/2015Q115$0.42$0.47$4.85 billion$4.90 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2015Q414$0.69$0.71$5.48 billion$5.36 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2014Q314$0.59$0.62$5.62 billion$5.10 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/16/2014Q214$0.51$0.54$5.53 billion$5.55 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/16/2014Q114$0.36$0.41$5.29 billion$5.24 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/22/2014Q413$0.58$0.58$5.72 billion$5.66 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/16/2013Q313$0.52$0.55$5.46 billion$5.37 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2013Q2 2013$0.44$0.46$5.53 billion$5.45 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/17/2013Q1 2013$0.41$0.42$5.42 billion$5.38 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/23/2013Q4 2012$1.50$1.51$10.58 billion$10.80 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/17/2012$1.28$1.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/18/2012$1.22$1.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/18/2012$1.00$1.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/25/2012$1.44$1.45ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/19/2011$1.17$1.18ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/20/2011$1.12$1.12ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/20/2011$0.90$0.91ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2011$1.29$1.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Abbott Laboratories (NYSE:ABT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.39$0.40$0.39
Q2 20165$0.51$0.54$0.53
Q3 20163$0.58$0.60$0.59
Q4 20162$0.66$0.67$0.67
Q1 20173$0.44$0.51$0.47
Q2 20172$0.60$0.61$0.61
Q3 20172$0.63$0.63$0.63
Q4 20172$0.70$0.71$0.71
Q1 20181$0.51$0.51$0.51
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Abbott Laboratories (NYSE:ABT)
Annual Dividend:$1.04
Dividend Yield:2.41%
Payout Ratio:68.87% (Based on Trailing 12 Months of Earnings)
47.27% (Based on Current Year Consensus EPS Estimate)
42.11% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:-21.80% (3 Year Average)

Dividend History for Abbott Laboratories (NYSE:ABT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
6/10/2016quarterly$0.262.75%7/13/20167/15/20168/15/2016Tweet This Announcement  Share This Announcement on StockTwits
2/19/2016quarterly$0.262.66%4/13/20164/15/20165/16/2016Tweet This Announcement  Share This Announcement on StockTwits
12/11/2015quarterly$0.262.32%1/13/20161/15/20162/16/2016Tweet This Announcement  Share This Announcement on StockTwits
9/17/2015quarterly$0.242.22%10/13/201510/15/201511/15/2015Tweet This Announcement  Share This Announcement on StockTwits
6/12/2015quarterly$0.242%7/13/20157/15/20158/15/2015Tweet This Announcement  Share This Announcement on StockTwits
2/20/2015quarterly$0.242.03%4/13/20154/15/20155/15/2015Tweet This Announcement  Share This Announcement on StockTwits
12/12/2014quarterly$0.242.21%1/13/20151/15/20152/13/2015Tweet This Announcement  Share This Announcement on StockTwits
9/11/2014quarterly$0.222.07%10/10/201410/15/201411/15/2014Tweet This Announcement  Share This Announcement on StockTwits
6/13/2014quarterly$0.222.21%7/11/20147/15/20148/15/2014Tweet This Announcement  Share This Announcement on StockTwits
2/21/2014quarterly$0.222.26%4/11/20144/15/20145/15/2014Tweet This Announcement  Share This Announcement on StockTwits
10/16/2013quarterly$0.222.37%1/13/20141/15/20142/15/2014Tweet This Announcement  Share This Announcement on StockTwits
9/12/2013quarterly$0.141.61%10/10/201310/15/201311/15/2013Tweet This Announcement  Share This Announcement on StockTwits
6/14/2013quarterly$0.141.52%7/11/20137/15/20138/15/2013Tweet This Announcement  Share This Announcement on StockTwits
2/15/2013quarterly$0.141.61%4/11/20134/15/20135/15/2013Tweet This Announcement  Share This Announcement on StockTwits
12/14/2012quarterly$0.140.86%1/11/20131/15/20132/15/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Abbott Laboratories (NYSE:ABT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/28/2016Hubert L AllenEVPSell3,400$37.14$126,276.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2016Jared WatkinSVPSell552$37.63$20,771.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Brian B YoorCFOSell565$39.49$22,311.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2016Deepak S NathSVPSell53$41.31$2,189.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2016Jaime ContrerasSVPSell462$41.78$19,302.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Brian B YoorCFOSell865$39.12$33,838.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Deepak S NathSVPSell793$39.27$31,141.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Robert B FordEVPSell1,706$39.28$67,011.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Robert E FunckVPSell1,333$39.30$52,386.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/22/2016Jared WatkinSVPSell554$39.09$21,655.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/16/2016Deepak S. NathSVPSell171$37.13$6,349.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015Miles D. WhiteCEOSell438,000$46.00$20,148,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Stephen R. FussellEVPSell13,096$50.46$660,824.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015Heather L MasonEVPSell13,500$47.45$640,575.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015Roger BirdSVPSell28,548$47.57$1,358,028.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2015J. Scott WhiteSVPSell12,483$46.68$582,706.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Jaime ContrerasSVPSell9,209$47.34$435,954.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015John M CapekEVPSell34,292$45.66$1,565,772.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2014Jaime ContrerasSVPSell51,600$44.07$2,274,012.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2014Miles D WhiteCEOSell440,800$42.52$18,742,816.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2014John LandgrafEVPSell17,293$39.38$680,998.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2014Katherine DoyleSVPSell6,639$39.01$258,987.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2014Robert FunckVPSell1,413$38.97$55,064.61View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014John LandgrafEVPSell1,583$39.10$61,895.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2014Michael WarmuthEVPSell11,430$36.21$413,880.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/6/2013Jean-Yves PaveeSVPSell5,855$37.46$219,328.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2013Stephen FussellEVPSell10,466$37.59$393,416.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2013Jaime ContrerasSVPSell25,368$36.85$934,810.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2013Heather L MasonSVPSell12,000$37.01$444,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2013William A OsbornDirectorBuy10,000$33.86$338,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Abbott Laboratories (NYSE:ABT)
DateHeadline
07/24/16 02:15 PMIs $50 Price Target Attainable For Abbott Laboratories (NYSE:ABT)? - Investor Newswire
07/23/16 02:15 PMStock Performance Rundown on Abbott Laboratories (NYSE:ABT) - Engelwood Daily
07/23/16 08:02 AMFriday Session Wrap-up for Abbott Laboratories (NYSE:ABT) - Engelwood Daily
07/23/16 08:02 AMAbbott Laboratories (NYSE:ABT) Updates On AlereInc (NYSE:ALR), St. Jude Medical, Inc. (NYSE:STJ) Deals - Market Exclusive
07/23/16 08:02 AMAnalysts Tips to Monitor: Abbott Laboratories (NYSE:ABT) , Grifols, S.A. (NASDAQ:GRFS) - Street Updates
07/23/16 08:02 AMPennsylvania Trust Co Lowers stake in Abbott Laboratories (ABT) - Trade Calls
07/22/16 07:16 PMRecent Product Launches Drive Growth For Abbott Laboratories In Q2’16
07/22/16 07:16 PMMechanics Bank Trust Department buys $5273417 stake in Abbott Laboratories (ABT)
07/22/16 07:16 PMAbbott Laboratories (ABT) Position Increased by Panagora Asset Management Inc
07/22/16 02:15 PMStock Attracting Analyst Attention: Abbott Laboratories (ABT) - The Voice Registrar
07/22/16 02:15 PMHC Stocks Growth: Abbott Laboratories (NYSE:ABT), Mast Therapeutics Inc (NYSEMKT:MSTX) - share market updates (press release)
07/22/16 02:15 PMCharter Trust Co buys $8916068 stake in Abbott Laboratories (ABT) - TheFounders Daily
07/22/16 12:14 PMHow Did Johnson & Johnson’s Segments Perform in 2Q16? -
07/22/16 10:25 AMAbbott Laboratories (NYSE:ABT) price target upped to $50 as recorded today by Barclays Capital
07/22/16 10:25 AMAbbott Laboratories: What Should You Do After Q2?
07/21/16 07:51 PMAbbott Laboratories Announces 3% Increase In Q2 Bottom Line
07/21/16 07:51 PMFocus On Abbott Labs Remains On Pending Deals
07/21/16 07:51 PMAbbott Labs Q2 top line up 3%; net income off 22%; shares up 3% premarket
07/21/16 07:51 PMStock Update: Abbott Laboratories (NYSE:ABT) – Abbott Reports Second-Quarter 2016 Results
07/21/16 07:51 PMAbbott (ABT) Beats on Earnings & Sales in Q2
07/21/16 07:51 PMAbbott Laboratories (ABT) Miles D. White on Q2 2016 Results - Earnings Call Transcript
07/21/16 02:15 PMStock Filling Investor's Pockets: Abbott Laboratories (NYSE:ABT) - TGP
07/21/16 02:15 PMFocus On Abbott Labs Remains On Pending Deals - Benzinga
07/21/16 10:29 AMJefferies Maintains Abbott Laboratories to Buy with Price Target $49.00 - TheFounders Daily
07/21/16 10:29 AMEarnings Focus and Crowd Sourced Sentiment Review for Abbott Laboratories (NYSE:ABT) - TGP
07/21/16 10:29 AMAbbott Labs (ABT) Stock Price Target Raised at Barclays - TheStreet.com
07/21/16 09:39 AMAbbott Laboratories :ABT-US: Earnings Analysis: Q2, 2016 By the Numbers : July 21, 2016 -
07/21/16 08:26 AMAbbott Labs (ABT) Stock Price Target Raised at Barclays -
07/21/16 07:40 AMOpioid Addiction: What To Do When A Loved One Is Hooked, According To Science -
07/21/16 07:00 AMHow Abbvie's Humira Undercuts The Drug Industry Price Defense -
07/20/16 02:59 PMPisani's market close: Big earnings today -
07/20/16 02:33 PMAbbott (ABT) Beats on Earnings & Sales in Q2, Maintains View -
07/20/16 02:26 PMStock Strength in Focus for Abbott Laboratories (NYSE:ABT) - Press Telegraph
07/20/16 02:26 PMBoyd Watterson Asset Managementoh buys $1724890 stake in Abbott Laboratories (ABT) - Trade Calls
07/20/16 11:25 AMAbbott sales beat on higher demand for medical devices - Reuters - ReutersAbbott sales beat on higher demand for medical devicesReutersAbbott Laboratories reported a better-than-expected 3.2 percent rise in quarterly sales, helped by strength in its medical device business. Sales in the medical device division rose 6.4 percent to $1.37 billion in the second quarter, driven primarily ...Abbott Results, Helped by Product Launches, Top ViewsWall Street JournalAbbott Quarterly Earnings Beat Estimates on Device SalesBloombergAbbott Labs (ABT) Stock Rising on Q2 Earnings BeatTheStreet.comNasdaq -Chicago Daily Herald -SFGate -Benzingaall 24 news articles »
07/20/16 10:24 AMEquity Roundup: Stock Performance Focus on Abbott Laboratories (NYSE:ABT) - Press Telegraph
07/20/16 10:24 AMDiamond Hill Capital Management INC Increased Abbott Laboratories (NYSE:ABT) by $64.63 Million as Shares Declined - Press Telegraph
07/20/16 10:24 AMAnalysts Holding Strong to their Buy Rating on: Abbott Laboratories (NYSE:ABT) - TGP
07/20/16 10:24 AMHC Stocks News Buzz: Abbott Laboratories (NYSE:ABT), Agilent Technologies Inc (NYSE:A) - share market updates (press release)
07/20/16 10:24 AMAbbott Labs (ABT) Stock Falling Ahead of Q2 Earnings Report - TheStreet.com
07/20/16 10:24 AMAbbott Labs (ABT) Stock Rising on Q2 Earnings Beat - TheStreet.com
07/20/16 08:16 AMInvestors Greet Abbott Q2 Earnings Number - Abbott Laboratories (NYSE: ABT) delivered better-than-expected adjusted earnings number for the second quarter while sales came in line with the predictions. Abbott reported 21.6 percent drop in profit to $615 million from $784 million while earnings dipped 23.1 percent to $0.40 a share from $0.52 a share in the year earlier quarter. On an adjusted basis, its earnings ...Full story available on Benzinga.com
07/20/16 07:15 AMAbbott Laboratories beats by $0.02, beats on revenue -
07/19/16 02:35 PMAbbott Labs (ABT) Stock Falling Ahead of Q2 Earnings Report -
07/19/16 02:15 PMStocks Plans To Gain Attentions- Abbott Laboratories (NYSE:ABT), B2Gold (NYSEMKT:BTG), Zayo Group (NYSE:ZAYO) - Seneca Globe
07/19/16 02:15 PMShares Lower on the Year Abbott Laboratories (NYSE:ABT) - Press Telegraph
07/19/16 02:15 PMInvestor Update: Earnings and Target Price Recap on Abbott Laboratories (NYSE:ABT) - Press Telegraph
07/19/16 02:15 PMStocks To Watch: United States Steel Corp. (X), Abbott Laboratories (ABT), Cliffs Natural Resources Inc. (CLF) - iStreetWire
07/19/16 01:45 PMSt. Jude Medical (STJ) Stock Lower Ahead of Q2 Results -
07/19/16 10:52 AMETF’s with exposure to Abbott Laboratories : July 19, 2016 -

Social

About Abbott Laboratories

Abbott Laboratories logoAbbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a line of healthcare products. The Company operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products. Its Established Pharmaceutical Products segment's therapeutic area portfolio of products includes gastroenterology products, women's health products, and respiratory drugs and vaccines.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: ABT
  • CUSIP: 00282410
Key Metrics:
  • Previous Close: $43.04
  • 50 Day Moving Average: $39.78
  • 200 Day Moving Average: $39.91
  • P/E Ratio: 28.50
  • P/E Growth: 2.11
  • Market Cap: $63.42B
  • Beta: 0.7
  • Current Year EPS Consensus Estimate: $2.2 EPS
  • Next Year EPS Consensus Estimate: $2.47 EPS
Additional Links:
Abbott Laboratories (NYSE:ABT) Chart for Sunday, July, 24, 2016